News Column

Instem: Nuvisan Pharma Services Selects Alphadas

June 17, 2014

Instem reported that Nuvisan Pharma Services has purchased the Alphadas clinical trials software solution suite for deployment in its Phase I unit located in Neu-Ulm, Germany.

According to a company release, Nuvisan selected Instem's Alphadas software suite based on its ability to support clinical development team's specific needs through configurations, the ability to integrate with other support systems through the unit and for Instem's rapid deployment services.

In addition to improving processes at their Phase I unit, Alphadas will be integrating with Nuvisan's central lab operations resulting in enhanced quality and consistency while simultaneously improving efficiencies and saving time.

"Following a thorough evaluation of several software solutions, and after visiting with clients of each vendor under consideration, it was clear that Alphadas by Instem would not only be replacing our existing system, but was the one solution that would truly be providing us with the platform we need to help our clients succeed," said James Dickinson, Head of Nuvisan's Phase I unit. "In addition to the technology, Instem is a well-respected, stable organization offering Nuvisan true subject matter expertise by staff that have run Phase I labs themselves. Bringing more than just software to us was an essential driver behind our decision and we are looking forward to a quick and efficient rollout of their system."

Nuvisan is a contract research organization providing clinical development and lab services.

Instem is a supplier of IT applications.

More information:

www.nuvisan.com

www.instem.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Beauty Close - Up


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters